Medicare AdvantageCoverageMedium impact
Genetic Testing for Hereditary Cardiovascular Disease - Medicare Advantage (Revised)
Humana·Cardiology, Genetics, Internal Medicine·Medicare Advantage
We identified it
Jun 30, 2026
Summary
This revised Medicare Advantage policy clarifies coverage for genetic testing to confirm diagnosis or predict risk for five hereditary cardiovascular conditions: CPVT, familial hypercholesterolemia, HCM, LQTS, and Marfan syndrome. The billing team must ensure claims for these genetic tests include appropriate medical necessity documentation linking to one of these five conditions.
Action Required
Immediately: Billing team must review all pending and recent genetic testing claims for hereditary cardiovascular conditions to ensure they are coded and documented to one of the five covered indications (CPVT, familial hypercholesterolemia, HCM, LQTS, or Marfan syndrome). Update claim submission templates and provider documentation reminders to reference these five specific conditions. Coordinate with providers and laboratory partners to confirm test orders include appropriate diagnosis codes. Claims lacking clear medical necessity tied to these conditions may be denied. Flag any genetic testing claims for other cardiac conditions for manual review.